
|Articles|May 3, 2021
ERT and Bioclinica Close Merger
Advertisement
ERT has announced
Joe Eazor is the CEO of the merged company, and the management team will be composed of a combination of both ERT and Bioclinica executives.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
Utilizing Tech Tools to Accelerate Drug Development
4
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
5






.png)



.png)



.png)
.png)
